AstraZeneca has agreed to acquire Belgian in vivo cell therapy biotech EsoBiotec, strengthening its position in the emerging field of treatments that can reprogramme immune cells inside patients ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

May 30, 2025 AstraZeneca agrees to $51 million settlement in Seroquel antitrust class action Drugmaker AstraZeneca has agreed to pay $50.9 million to settle a class action lawsuit in U.S. court ...